[The treatment of protracted forms of Flexner dysentery].
The clinical efficacy of sodium nucleinate (SN) combined with splenin and quercetin given for lingering Flexner's dysentery in a group of 43 patients was compared with that of routine therapy used in a group of the same number of patients. It has been established that the above drug combination favours the elimination of the pathological symptoms of dyspepsia, the arrest of bacterial isolation and normalization of the immune status. Provided the effect of the combined drug treatment is insufficient, the method of choice is the administration of gene engineering alpha 2-interferon (reaferon) in combination with tocopherol acetate and rectal suppositories containing methyluracil.
Iushchuk
N D
ND
Frolov
V M
VM
Peresadin
N A
NA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use; D011794:Quercetin / Q000627:therapeutic use; D012331:RNA, Fungal / Q000627:therapeutic use; D012763:Shigella flexneri; D013946:Thymopoietins / Q000627:therapeutic use; D013997:Time Factors
D000276:Adjuvants, Immunologic; D009696:Nucleic Acids; D012331:RNA, Fungal; D013946:Thymopoietins; C032841:thymopoietin III; C013683:sodium nucleinate; D011794:Quercetin
Lechenie zatiazhnykh form dizenterii Fleksnera.